Practical considerations in the use of stable isotope labelled compounds as tracers in clinical studies.
Increasingly widespread usage of stable isotope tracers to aid clinical diagnosis and support basic research has stemmed from both advances in mass spectrometry and the availability of competitively priced labelled compounds. Stable isotopes have been used generally to investigate normal and abnormal metabolic pathways, to estimate energy expenditure and body composition and to quantitate substrate flux and oxidation rates. Despite the fact that the underlying principles relating to the use of stable isotopes for in vivo studies are straightforward, careful consideration must be given to all aspects of human studies. This review highlights some of these, including choice of label and tracer molecule, mode of tracer administration and sampling site, analytical instrumentation, interpretation of data and ethical constraints.
Thompson
G N
GN
Nutrition Research Group, Clinical Research Centre, Harrow, UK.
Pacy
P J
PJ
Ford
G C
GC
Halliday
D
D
D002247:Carbon Isotopes; D003365:Costs and Cost Analysis; D003903:Deuterium; D004992:Ethics, Medical; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007554:Isotopes; D009587:Nitrogen Isotopes; D010084:Oxidation-Reduction; D010103:Oxygen Isotopes
D002247:Carbon Isotopes; D007554:Isotopes; D009587:Nitrogen Isotopes; D010103:Oxygen Isotopes; D003903:Deuterium